Simergent

Human factors testing in a novel automated peritoneal dialysis system

Simergent's Archimedes APD cycler receives FDA 510(k) clearance after successful human factors usability study in conjunction with Northwestern University and Indiana University

Simergent is showcasing its FDA-approved Archimedes Automated Peritoneal Dialysis Device at ASN Kidney Week 2025 and will be at Booth #2403.

In Vitro study comparing touch contamination of Simergent's tubing set bag connectors to competitors. Potential to reduce touch contamination, which is a common cause of peritonitis.

Simergent's team

Simergent is developing an affordable automated peritoneal dialysis device for emerging markets including Mexico, China, India, and other countries.

Simergent, a kidney care startup founded in 2016 by Steve J. Lindo and Rick Pendergraft, PhD, developed a gravity-based peritoneal dialysis system called Archimedes. The company achieved FDA 510(k) clearance for the Archimedes system in October, marking a milestone for its innovative approach to dialysis technology.

Nov 2025healio.comNews article

Simergent receives FDA Breakthrough Device Designation for its Archimedes™ automated peritoneal dialysis (APD) system, enabling at-home kidney failure treatment. The system automates fluid exchanges for patients, reducing reliance on in-center dialysis. Simergent specializes in developing innovative solutions for kidney disease management.

Oct 2025europeanhhm.comNews article

Simergent receives FDA 510(k) clearance for its Archimedes™ automated peritoneal dialysis (APD) system, designed for treating patients with End Stage Kidney Disease (ESKD) in clinical and home settings. The system automates peritoneal dialysis, a treatment method that filters waste from the blood using the peritoneal membrane. Simergent focuses on improving kidney failure treatment options with innovative medical devices.

Oct 2025BioSpaceNews article

Simergent receives FDA 510(k) clearance for its Archimedes™ automated peritoneal dialysis (APD) system, designed for treating patients with End Stage Kidney Disease (ESKD) in clinical and home environments. The system automates peritoneal dialysis, a treatment method for kidney failure patients. Simergent focuses on advancing kidney disease therapies through innovative medical devices.

Oct 2025Yahoo FinanceNews article